Competition among private insurers and providers pushes innovation — in treatments, technology, and customer service — in ways a single government-run system might not, since providers aren't competing for patients under one payer. Supporters point to the U.S.'s role in developing many major medical innovations and drugs. Supporters argue competition, not centralized control, has historically driven medical innovation. Supporters argue this competitive dynamic has historically driven meaningful advances in treatment and technology.